Loading clinical trials...
Loading clinical trials...
A Pilot Study of Functional Remediation for Bipolar Disorder: Feasibility and Preliminary Efficacy
Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.
Age
18 - 55 years
Sex
ALL
Healthy Volunteers
No
University of Michigan Depression Center
Ann Arbor, Michigan, United States
Start Date
November 17, 2017
Primary Completion Date
December 10, 2018
Completion Date
December 20, 2018
Last Updated
February 28, 2019
30
ACTUAL participants
Functional Remediation
OTHER
Lead Sponsor
University of Michigan
NCT04480918
NCT07140913
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions